GlobalData on MSN
FDA grants breakthrough designation to PathAI for pathology solution
The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.
BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- PathAI, a leader in AI-powered pathology solutions, today announced the launch of PathAssist Derm, an AI tool for orienting, identifying, and measuring skin ...
PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation ...
Hosted on MSN
PathAI launches AI tool to measure skin lesions
PathAI has launched the PathAssist Derm AI tool, which is designed for orienting, detecting, and measuring skin lesions. This new offering, now available on the AISight image management system (IMS), ...
(MENAFN- GlobeNewsWire - Nasdaq) Now available on the AISight® Platform, PathAssist Derm is an AI-assisted histopathology tool that enhances dermatopathology research workflows, accelerating skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results